Compare BNTC & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTC | WNEB |
|---|---|---|
| Founded | 1995 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.4M | 271.3M |
| IPO Year | 2020 | 2001 |
| Metric | BNTC | WNEB |
|---|---|---|
| Price | $7.92 | $13.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $23.75 | $15.00 |
| AVG Volume (30 Days) | ★ 154.2K | 29.9K |
| Earning Date | 11-13-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 6.67 | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $44,000.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | ★ N/A | $17.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.89 | $11.74 |
| 52 Week High | $14.39 | $15.01 |
| Indicator | BNTC | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 37.62 | 34.10 |
| Support Level | N/A | $12.90 |
| Resistance Level | $13.87 | $14.19 |
| Average True Range (ATR) | 0.66 | 0.31 |
| MACD | -0.08 | -0.07 |
| Stochastic Oscillator | 5.18 | 8.00 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.